DK0746551T3 - Optisk rene 4-aryl-2-hydroxytetronsyrer - Google Patents
Optisk rene 4-aryl-2-hydroxytetronsyrerInfo
- Publication number
- DK0746551T3 DK0746551T3 DK95911075T DK95911075T DK0746551T3 DK 0746551 T3 DK0746551 T3 DK 0746551T3 DK 95911075 T DK95911075 T DK 95911075T DK 95911075 T DK95911075 T DK 95911075T DK 0746551 T3 DK0746551 T3 DK 0746551T3
- Authority
- DK
- Denmark
- Prior art keywords
- optically pure
- aryl
- treatment
- cyclooxygenase
- hydroxytetronic acids
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
- C07D339/08—Six-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/62—Three oxygen atoms, e.g. ascorbic acid
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/201,775 US5399721A (en) | 1990-01-12 | 1994-02-25 | Synthesis of optically pure 4-aryl-2-hydroxytetronic acids |
US08/350,205 US5504108A (en) | 1990-01-12 | 1994-12-05 | Optically pure 4-aryl-2-hydroxytetronic acids |
PCT/US1995/002183 WO1995023139A1 (en) | 1994-02-25 | 1995-02-22 | Optically pure 4-aryl-2-hydroxytetronic acids |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0746551T3 true DK0746551T3 (da) | 2003-01-06 |
Family
ID=26897085
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK95911075T DK0746551T3 (da) | 1994-02-25 | 1995-02-22 | Optisk rene 4-aryl-2-hydroxytetronsyrer |
Country Status (10)
Country | Link |
---|---|
US (1) | US5504108A (da) |
EP (1) | EP0746551B1 (da) |
JP (1) | JP3241735B2 (da) |
AT (1) | ATE223395T1 (da) |
CA (1) | CA2184068A1 (da) |
DE (1) | DE69528044T2 (da) |
DK (1) | DK0746551T3 (da) |
ES (1) | ES2182890T3 (da) |
PT (1) | PT746551E (da) |
WO (1) | WO1995023139A1 (da) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6005000A (en) | 1996-08-22 | 1999-12-21 | Oxis International, Inc. | 5,5-Disubstituted-3, 4-dihydroxy-2(5H)-furanones and methods of use therefor |
DE69913390D1 (de) * | 1999-12-29 | 2004-01-15 | Oxis Isle Of Man Ltd | Methode zur trennung von racemischen mischungen von 5-substituierten 4-hydroxy-2-furanonen |
EP1303265B1 (en) | 2000-07-20 | 2007-07-11 | Lauras AS | Use of cox-2 inhibitors as immunostimulants in the treatment of hiv or aids |
ATE556996T1 (de) * | 2001-11-30 | 2012-05-15 | Nippon Catalytic Chem Ind | ßOPTISCH AKTIVE MANDELS URE UND DEREN DERIVATE, UND VERFAHREN ZU DEREN KRISTALLISIERUNGß |
CN101343243A (zh) * | 2001-12-21 | 2009-01-14 | 奥索-麦克尼尔药品公司 | 制备氨基甲酸2-(取代苯基)-2-羟基-乙酯的方法 |
IL162405A0 (en) * | 2001-12-21 | 2005-11-20 | Ortho Mcneil Pharm Inc | Process for preparing 2-(substituted phenyl)-2-hydroxy -ethyl carbamates |
CN102413825A (zh) | 2009-04-29 | 2012-04-11 | 阿马里纳股份公司 | 含有epa和心血管剂的药物组合物以及使用其的方法 |
GB2512863A (en) * | 2013-04-09 | 2014-10-15 | Pornthip Lattmann | Medicinal applications of arylated hydroxy-tetronic acids |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2830268B2 (ja) * | 1989-01-21 | 1998-12-02 | 武田薬品工業株式会社 | アスコルビン酸誘導体の製造法 |
US5095126A (en) * | 1990-01-12 | 1992-03-10 | Ohio State University Research Foundation | Efficient synthesis for optically pure stereogenically labile 4-substituted-2-hydroxytetronic acids |
US5071872A (en) * | 1990-08-14 | 1991-12-10 | The Ohio State University Research Foundation | Method for improving interleukin-2 activity using aci-reductone compounds |
-
1994
- 1994-12-05 US US08/350,205 patent/US5504108A/en not_active Expired - Fee Related
-
1995
- 1995-02-22 PT PT95911075T patent/PT746551E/pt unknown
- 1995-02-22 ES ES95911075T patent/ES2182890T3/es not_active Expired - Lifetime
- 1995-02-22 DK DK95911075T patent/DK0746551T3/da active
- 1995-02-22 CA CA002184068A patent/CA2184068A1/en not_active Abandoned
- 1995-02-22 AT AT95911075T patent/ATE223395T1/de not_active IP Right Cessation
- 1995-02-22 WO PCT/US1995/002183 patent/WO1995023139A1/en active IP Right Grant
- 1995-02-22 DE DE69528044T patent/DE69528044T2/de not_active Expired - Fee Related
- 1995-02-22 EP EP95911075A patent/EP0746551B1/en not_active Expired - Lifetime
- 1995-02-22 JP JP52242295A patent/JP3241735B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
PT746551E (pt) | 2003-01-31 |
DE69528044D1 (de) | 2002-10-10 |
ES2182890T3 (es) | 2003-03-16 |
EP0746551B1 (en) | 2002-09-04 |
ATE223395T1 (de) | 2002-09-15 |
CA2184068A1 (en) | 1995-08-31 |
US5504108A (en) | 1996-04-02 |
DE69528044T2 (de) | 2003-04-17 |
JPH10500663A (ja) | 1998-01-20 |
WO1995023139A1 (en) | 1995-08-31 |
EP0746551A1 (en) | 1996-12-11 |
JP3241735B2 (ja) | 2001-12-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS4695A (is) | (Metýlsúlfónýl)fenýl-2-(5H)-fúranón sem sýklóoxýgenasa-2 tálmar | |
EP0462812A3 (en) | Pyran derivatives as inhibitors of 5-lipoxygenase | |
PT937048E (pt) | Derivados heterociclicos que inibem factor xa | |
EA200000358A1 (ru) | Способ получения диарилпиридинов, полезных в качестве ингибиторов cox-2 | |
DZ3402A1 (fr) | Cyclopentanoindoles, compositions contenant ces composes et methodes de traitement | |
CR6540A (es) | Trifluorobutenos nematicidas | |
AR014261A1 (es) | Compuestos hipolipidemicos de benzotiazepina, composiciones y proceso para su preparacion | |
ATE269290T1 (de) | Benzoylderivate | |
DE69712042D1 (de) | Thiazolylbenzofuranderivate und pharmazeutische zusammensetzungen die sie enthalten | |
DE69920757D1 (de) | Immunsuppressive wirkungen von pteridinderivaten | |
PT77125A (en) | Process for preparing triphenylimidazolyloxy-alkanoic acids and their derivatives and of pharmaceutical compositions containing these compounds | |
ATE212343T1 (de) | 3,4-diaryl-2-hydroxy-2,5-dihydrofurane als wirkstoffvorstufen von cox-2 inhibitoren | |
ATE60579T1 (de) | Pyrrolidinamid-derivate mit antipropylendopeptidase-wirkung, zusammenstellungen, die sie enthalten, verfahren zu ihrer herstellung und heilmittel, die sie enthalten. | |
ATE131154T1 (de) | Phenylalkan(en)säuren. | |
DK0746551T3 (da) | Optisk rene 4-aryl-2-hydroxytetronsyrer | |
DE69121502D1 (de) | Prozess zur darstellung von aspartam aus einem diketopiperazin sowie neue zwischenprodukte und derivate dafür | |
EA200000204A1 (ru) | Производные пирролопирролона в качестве ингибиторов эластазы нейтрофилов | |
ES2076838T3 (es) | Nuevo derivado de la isoindolinona, su preparacion y las composiciones farmaceuticas que le contienen. | |
ATE330604T1 (de) | Behandlung von manischen erkrankungen | |
ES2091285T3 (es) | 2-hidroxi-1,2,3-propanotricarboxilato de 3-((5-metil-2-furanil)-metil)-n-(4-piperidinil)-3h-imidazo-(4,5-b)-piridin-2-amina. | |
FR2355846A1 (fr) | Esters de penicillines utilisables comme medicaments | |
ES2082212T3 (es) | Nuevos inhibidores de alfa-glucosidasa. | |
DK275784D0 (da) | 6-(aminomethyl)penicillansyre-1,1-dioxid-estere, som er hydrolyserbare under fysiologiske betingelser, og aminobeskyttede 6-(aminomethyl)penicillansyre-forbindelser til anvendelse som mellemprodukter herfor | |
ITMI920082A1 (it) | Derivati solforati di acidi biliari | |
MX9605760A (es) | Sintesis de acidos 4-alquenil o 4-alcanil-2-hidroxitetronicos opticamente puros. |